Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
Author(s) -
Sameer S. Kadri,
Jennifer Adjemian,
Yi Ling Lai,
Alicen B. Spaulding,
Emily Ricotta,
D. Rebecca Prevots,
Tara N. Palmore,
Chanu Rhee,
Michael Klompas,
John P. Dekker,
John H. Powers,
Anthony F. Suffredini,
David C. Hooper,
Scott K. Fridkin,
Robert L. Danner
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy378
Subject(s) - medicine , bacteremia , cohort , retrospective cohort study , gram , gram negative bacterial infections , intensive care medicine , antibiotics , microbiology and biotechnology , bacteria , genetics , biology
Resistance to all first-line antibiotics necessitates the use of less effective or more toxic "reserve" agents. Gram-negative bloodstream infections (GNBSIs) harboring such difficult-to-treat resistance (DTR) may have higher mortality than phenotypes that allow for ≥1 active first-line antibiotic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom